Literature DB >> 21867767

RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase.

Iraida G Sharina1, Gilbert J Cote, Emil Martin, Marie-Francoise Doursout, Ferid Murad.   

Abstract

Soluble guanylyl cyclase (sGC) is a key protein in the nitric oxide (NO)/-cGMP signaling pathway. sGC activity is involved in a number of important physiological processes including smooth muscle relaxation, neurotransmission and platelet aggregation and adhesion. Regulation of sGC expression and activity emerges as a crucial factor in control of sGC function in normal and pathological conditions. Recently accumulated evidence strongly indicates that the regulation of sGC expression is a complex process modulated on several levels including transcription, post-transcriptional regulation, translation and protein stability. Presently our understanding of mechanisms governing regulation of sGC expression remains very limited and awaits systematic investigation. Among other ways, the expression of sGC subunits is modulated at the levels of mRNA abundance and transcript diversity. In this review we summarize available information on different mechanisms (including transcriptional activation, mRNA stability and alternative splicing) involved in the modulation of mRNA levels of sGC subunits in response to various environmental clues. We also summarize and cross-reference the information on human sGC splice forms available in the literature and in genomic databases. This review highlights the fact that the study of the biological role and regulation of sGC splicing will bring new insights to our understanding of NO/cGMP biology. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21867767      PMCID: PMC3190046          DOI: 10.1016/j.niox.2011.08.001

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  100 in total

1.  Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.

Authors:  Pieter Vermeersch; Emmanuel Buys; Peter Pokreisz; Glenn Marsboom; Fumito Ichinose; Patrick Sips; Marijke Pellens; Hilde Gillijns; Marc Swinnen; Amanda Graveline; Desire Collen; Mieke Dewerchin; Peter Brouckaert; Kenneth D Bloch; Stefan Janssens
Journal:  Circulation       Date:  2007-08-06       Impact factor: 29.690

2.  Gender-specific hypertension and responsiveness to nitric oxide in sGCalpha1 knockout mice.

Authors:  Emmanuel S Buys; Patrick Sips; Pieter Vermeersch; Michael J Raher; Elke Rogge; Fumito Ichinose; Mieke Dewerchin; Kenneth D Bloch; Stefan Janssens; Peter Brouckaert
Journal:  Cardiovasc Res       Date:  2008-03-13       Impact factor: 10.787

Review 3.  Messenger RNA regulation: to translate or to degrade.

Authors:  Ann-Bin Shyu; Miles F Wilkinson; Ambro van Hoof
Journal:  EMBO J       Date:  2008-02-06       Impact factor: 11.598

4.  An internal ribosome entry site mediates the initiation of soluble guanylyl cyclase beta2 mRNA translation.

Authors:  Roberto I Vazquez-Padron; Si M Pham; Dania Mateu; Sheik Khan; Abdelouahab Aitouche
Journal:  FEBS J       Date:  2008-07       Impact factor: 5.542

5.  Alpha1 soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activity.

Authors:  Iraida G Sharina; Filip Jelen; Elena P Bogatenkova; Anthony Thomas; Emil Martin; Ferid Murad
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

6.  Gastric motility in soluble guanylate cyclase alpha 1 knock-out mice.

Authors:  Gwen Vanneste; Ingeborg Dhaese; Patrick Sips; Emmanuel Buys; Peter Brouckaert; Romain A Lefebvre
Journal:  J Physiol       Date:  2007-08-23       Impact factor: 5.182

7.  Involvement of soluble guanylate cyclase alpha(1) and alpha(2), and SK(Ca) channels in NANC relaxation of mouse distal colon.

Authors:  Ingeborg Dhaese; Gwen Vanneste; Patrick Sips; Emmanuel Buys; Peter Brouckaert; Romain A Lefebvre
Journal:  Eur J Pharmacol       Date:  2008-05-23       Impact factor: 4.432

8.  Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.

Authors:  Sofie Nimmegeers; Patrick Sips; Emmanuel Buys; Peter Brouckaert; Johan Van de Voorde
Journal:  Cardiovasc Res       Date:  2007-06-12       Impact factor: 10.787

9.  Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.

Authors:  R T Schermuly; J-P Stasch; S S Pullamsetti; R Middendorff; D Müller; K-D Schlüter; A Dingendorf; S Hackemack; E Kolosionek; C Kaulen; R Dumitrascu; N Weissmann; J Mittendorf; W Klepetko; W Seeger; H A Ghofrani; F Grimminger
Journal:  Eur Respir J       Date:  2008-06-11       Impact factor: 16.671

10.  Characterization of the human alpha1 beta1 soluble guanylyl cyclase promoter: key role for NF-kappaB(p50) and CCAAT-binding factors in regulating expression of the nitric oxide receptor.

Authors:  Martín L Marro; Concepción Peiró; Catherine M Panayiotou; Reshma S Baliga; Sabine Meurer; Harald H H W Schmidt; Adrian J Hobbs
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

View more
  9 in total

Review 1.  Role of sGC-dependent NO signalling and myocardial infarction risk.

Authors:  Jana Wobst; Thorsten Kessler; Tan An Dang; Jeanette Erdmann; Heribert Schunkert
Journal:  J Mol Med (Berl)       Date:  2015-03-04       Impact factor: 4.599

2.  Alternative splicing impairs soluble guanylyl cyclase function in aortic aneurysm.

Authors:  Emil Martin; Eva Golunski; Susan T Laing; Anthony L Estrera; Iraida G Sharina
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-19       Impact factor: 4.733

3.  The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies.

Authors:  I G Sharina; M Sobolevsky; A Papakyriakou; N Rukoyatkina; G A Spyroulias; S Gambaryan; E Martin
Journal:  Br J Pharmacol       Date:  2015-02-10       Impact factor: 8.739

4.  Hypoxia induces downregulation of soluble guanylyl cyclase β1 by miR-34c-5p.

Authors:  Xiaojian Xu; Shumin Wang; Juan Liu; Dou Dou; Limei Liu; Zhengju Chen; Liping Ye; Huixia Liu; Qiong He; J Usha Raj; Yuansheng Gao
Journal:  J Cell Sci       Date:  2012-10-04       Impact factor: 5.285

5.  Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content.

Authors:  Arnab Ghosh; Johannes-Peter Stasch; Andreas Papapetropoulos; Dennis J Stuehr
Journal:  J Biol Chem       Date:  2014-04-14       Impact factor: 5.157

6.  The amino-terminus of nitric oxide sensitive guanylyl cyclase α₁ does not affect dimerization but influences subcellular localization.

Authors:  Jan R Kraehling; Mareike Busker; Tobias Haase; Nadine Haase; Markus Koglin; Monika Linnenbaum; Soenke Behrends
Journal:  PLoS One       Date:  2011-09-30       Impact factor: 3.240

Review 7.  Maturation, inactivation, and recovery mechanisms of soluble guanylyl cyclase.

Authors:  Dennis J Stuehr; Saurav Misra; Yue Dai; Arnab Ghosh
Journal:  J Biol Chem       Date:  2021-01-26       Impact factor: 5.157

8.  Hydrogen peroxide alters splicing of soluble guanylyl cyclase and selectively modulates expression of splicing regulators in human cancer cells.

Authors:  Gilbert J Cote; Wen Zhu; Anthony Thomas; Emil Martin; Ferid Murad; Iraida G Sharina
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

9.  Nitric Oxide Plays a Key Role in Ovariectomy-Induced Apoptosis in Anterior Pituitary: Interplay between Nitric Oxide Pathway and Estrogen.

Authors:  Sonia A Ronchetti; Leticia I Machiavelli; Fernanda A Quinteros; Beatriz H Duvilanski; Jimena P Cabilla
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.